DK0608336T3 - Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling - Google Patents

Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling

Info

Publication number
DK0608336T3
DK0608336T3 DK92921974T DK92921974T DK0608336T3 DK 0608336 T3 DK0608336 T3 DK 0608336T3 DK 92921974 T DK92921974 T DK 92921974T DK 92921974 T DK92921974 T DK 92921974T DK 0608336 T3 DK0608336 T3 DK 0608336T3
Authority
DK
Denmark
Prior art keywords
nynoxymes
azabicycloaryl
arylene
acetylene
treatment
Prior art date
Application number
DK92921974T
Other languages
English (en)
Inventor
David Jeffrey Lauffer
Walter Hamilton Moos Moos
Michael Raymond Pavia
Haile Tecle
Anthony Jerome Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0608336T3 publication Critical patent/DK0608336T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Indole Compounds (AREA)
DK92921974T 1991-10-16 1992-10-09 Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling DK0608336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/778,412 US5306718A (en) 1990-03-06 1991-10-16 Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
PCT/US1992/008642 WO1993008192A1 (en) 1991-10-16 1992-10-09 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment

Publications (1)

Publication Number Publication Date
DK0608336T3 true DK0608336T3 (da) 1999-01-18

Family

ID=25113261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921974T DK0608336T3 (da) 1991-10-16 1992-10-09 Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling

Country Status (17)

Country Link
US (2) US5306718A (da)
EP (1) EP0608336B1 (da)
JP (1) JP3367670B2 (da)
KR (1) KR100241479B1 (da)
AT (1) ATE166354T1 (da)
AU (1) AU658685B2 (da)
CA (1) CA2115443C (da)
DE (1) DE69225601T2 (da)
DK (1) DK0608336T3 (da)
ES (1) ES2119823T3 (da)
FI (1) FI106797B (da)
NO (1) NO302072B1 (da)
NZ (1) NZ244726A (da)
PH (1) PH31431A (da)
PT (1) PT100961B (da)
WO (1) WO1993008192A1 (da)
ZA (1) ZA927973B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity
AUPM910994A0 (en) * 1994-10-28 1994-11-24 Commonwealth Scientific And Industrial Research Organisation Bisallyloxyimides
US5534522A (en) * 1995-06-07 1996-07-09 Warner-Lambert Company (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
US6168912B1 (en) 1996-01-23 2001-01-02 Martek Biosciences Corporation Method and kit for making a multidimensional combinatorial chemical library
AU741566B2 (en) * 1997-01-27 2001-12-06 Warner-Lambert Company Single pot process for producing (Z)-azabicyclo oxime ethers
US6924313B1 (en) 1999-09-23 2005-08-02 Pfizer Inc. Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6677341B2 (en) * 1999-09-23 2004-01-13 Pharmacia Corporation (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
KR100465277B1 (ko) * 2002-01-24 2005-01-13 한국과학기술연구원 신규한 옥심계 아자 두 고리 화합물 및 그 제조방법
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479346A (en) * 1961-08-08 1969-11-18 Sterling Drug Inc N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines
US3502692A (en) * 1962-06-13 1970-03-24 American Cyanamid Co Cyclic nitroxides and process for preparing same
DE2019536A1 (de) * 1970-04-23 1971-11-11 Basf Ag Oximcarbamate
DE2552176A1 (de) * 1975-11-21 1977-06-02 Hoechst Ag Neue piperidin-derivate, ihre herstellung und verwendung
US4341795A (en) * 1975-12-01 1982-07-27 Union Carbide Corporation Asymmetrical bis-carbamate compounds
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
NZ226000A (en) * 1987-09-10 1991-06-25 Merck Sharp & Dohme Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2115443C (en) 2003-05-13
DE69225601T2 (de) 1998-12-17
AU658685B2 (en) 1995-04-27
EP0608336A1 (en) 1994-08-03
PH31431A (en) 1998-11-03
AU2783592A (en) 1993-05-21
FI941699A (fi) 1994-04-13
ES2119823T3 (es) 1998-10-16
US5306718A (en) 1994-04-26
NZ244726A (en) 1995-09-26
NO302072B1 (no) 1998-01-19
ATE166354T1 (de) 1998-06-15
KR100241479B1 (ko) 2000-03-02
JP3367670B2 (ja) 2003-01-14
JPH07500337A (ja) 1995-01-12
EP0608336B1 (en) 1998-05-20
US5482938A (en) 1996-01-09
PT100961A (pt) 1993-11-30
DE69225601D1 (de) 1998-06-25
CA2115443A1 (en) 1993-04-29
ZA927973B (en) 1994-04-15
NO941365L (no) 1994-04-15
PT100961B (pt) 1999-07-30
NO941365D0 (no) 1994-04-15
FI106797B (fi) 2001-04-12
FI941699A0 (fi) 1994-04-13
WO1993008192A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
DK0608336T3 (da) Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling
CA2037541A1 (en) Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
DE59308619D1 (de) Germicide wirkstoffkombinationen
ZA917744B (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles.
NZ506574A (en) Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
MX9800411A (es) Compuestos quimicos.
DK0463969T3 (da) Hidtil ukendte 4-aminosmørsyreforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske præparater, som indeholder dem
DE69433148D1 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
DK0677116T3 (da) Fremgangsmåde til fremstilling af immunosuppressive midler og en ny mikroorganismeart til anvendelse deri
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
CA2241845A1 (en) 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity
MY108849A (en) Novel compound
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.
DE3770433D1 (de) 4-oxo-1,3-benzodioxan-derivat.
TH13390EX (th) อนุพันธ์ของอินโดลและอินดาโซลสำหรับใช้รักษาและ ป้องกันผิดปกติเกี่ยวกับสมองใหญ่, การเตรียมและ การใช้สารเหล่านั้น
EA200200574A1 (ru) НОВЫЕ ЦИКЛИЧЕСКИЕ α-АМИНО-γ-ГИДРОКСИАМИДНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ